Not checkedNot checked for notices yet.
Meeting abstracts from the Annual Conference on Hereditary Cancers 2016
C. Cybulski, W. Kluźniak, T. Huzarski and 147 more
Hereditary Cancer in Clinical Practice · 2017
doi:10.1186/s13053-017-0081-x (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
2):A1We tested over 20, 000 genes by whole-exome sequencing in 144 Polish women with breast cancer from families with strong aggregation of this tumor.We identified a new breast cancer susceptibility gene (RECQL).In Poland, there is one major founder mutations of RECQL.Our results suggest that the risk of breast cancer among the carriers is increased over 5-fold.In addition, we detected two PALB2 founder mutations in our population which predispose to poor prognosis breast cancer.Over half of breast cancer patients with a PALB2 mutation died within 10 years from the diagnosis.The survival among women with breast cancer caused by mutations of PALB2 strongly depended on tumor size.Among mutation carriers with tumors smaller than 2 cm, 10-year survival was 82%.In contrast, among mutation carriers with tumors greater than 2 cm 10-year survival was only 32%.In summary, our research enabled to identify new determinants (inherited mutations) for breast cancer, the most common malignant tumor in women.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.